Overview

Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The investigators want to try to improve information processing in schizophrenic patients via pharmacological intervention. The hypothesis is that decreased noradrenergic activity will normalize information processing (PPI, P50 gating, P300, and mismatch negativity) in patients with schizophrenia.
Phase:
N/A
Details
Lead Sponsor:
Birte Glenthoj
Collaborators:
Glostrup University Hospital, Copenhagen
Lundbeck Foundation
University of Copenhagen
Treatments:
Clonidine